Despite raising the price of its IPO twice, Caris Life Sciences Inc. left money on the table with a 33% increase in price as soon as trading commenced on the Nasdaq, though no one is squawking about ...

Heartflow's quarterly loss widened over the year-ago period, the healthcare company disclosed in its paperwork for a U.S.

Cancer diagnostic firm Caris Life Sciences saidMonday it is targeting a valuation of up to $5.3 billion in its U.S. initial public offering, as the market for new listings rebounds.

DOGE cuts are leading to new warnings in filings from biotech and health-care companies looking to IPO stateside. The big ...

Caris Life Sciences, Inc. (CAI) is planning to raise $400 million in an initial public offering on Wednesday, June 18th, IPO Scoop reports. The company will be issuing 23,500,000 shares at $16.00 ...

In any case, Chime is the June IPO that's sure to be a needle mover. Caris Life Sciences Up next, we have Caris Life Sciences (NASDAQ:CAI), which is poised to debut with a price in the $16-18 ...

Caris Life Sciences, which is backed by Sixth Street and JH Whitney, has filed for an IPO. Headquartered in Irving, Texas, Caris Life Sciences is a medical tech company. The IPO price is expected ...

Type a keyword to start your search. NEWS. Go to full news search ...

Our Privacy Statement & Cookie Policy. All websites use cookies to improve your online experience. They were placed on your computer when you launched this website.